IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $230,000 | +11.1% | 5,203 | -6.8% | 0.00% | 0.0% |
| Q1 2022 | $207,000 | +1.0% | 5,583 | +8.6% | 0.00% | 0.0% |
| Q2 2021 | $205,000 | -11.3% | 5,140 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $231,000 | -22.2% | 5,140 | -2.0% | 0.00% | 0.0% |
| Q4 2020 | $297,000 | +19.3% | 5,246 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $249,000 | -17.5% | 5,246 | +2.5% | 0.00% | -50.0% |
| Q2 2020 | $302,000 | +24.8% | 5,116 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $242,000 | -21.7% | 5,116 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $309,000 | +14.4% | 5,116 | +13.6% | 0.00% | 0.0% |
| Q3 2019 | $270,000 | -6.6% | 4,503 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $289,000 | -21.0% | 4,503 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $366,000 | +50.6% | 4,503 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $243,000 | +4.7% | 4,503 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $232,000 | +10.0% | 4,503 | +7.5% | 0.00% | 0.0% |
| Q4 2017 | $211,000 | -0.5% | 4,190 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $212,000 | -5.8% | 4,190 | +15.2% | 0.00% | -50.0% |
| Q4 2015 | $225,000 | – | 3,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |